S O Langley

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo

S O Langley, CM Masterson, EP Batty et al. · European Respiratory Journal · 1998 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.

Anderson Pb, S O Langley, Peter D. Mooney et al. · PubMed · 2002 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +17